The utility of the clinical pulmonary infection score

Journal of Intensive Care Medicine

Volumn 24, Issue 1, 2009, Pages 26-34

  Rosbolt, Margaret Bonnie ^a   Sterling, Emily S ^b   Fahy, Brenda G ^c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Clinical pulmonary infection score; Review; Ventilator associatedpneumonia; nosocomial pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

BACTERIUM CULTURE; BODY TEMPERATURE; LEUKOCYTE COUNT; LUNG LAVAGE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; THERAPY DELAY; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 58349084720     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066608327097     Document Type: Review

References (66)

1. Bonten MJM, Kollef MH, Hall JB Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis. 2004 ; 38: 1141-1149.
2. Safdar N., Dezfulian C., Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005 ; 33: 2184-2193.
3. Rello J., Ollendorf DA, Oster G., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002 ; 122: 2115-2121.
4. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003 ; 31: 1312-1317.
5. Heyland DK, Cook DJ, Griffith L., Keenan SP, Brun-Buisson C. and the Canadian Critical Care Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999 ; 159: 1249-1256.
6. Kollef MH Ventilator-associated pneumonia: a multi-variate analysis. JAMA. 1993 ; 270: 1965-1970.
7. Dupont H., Mentec H., Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001 ; 27: 355-362.
8. Kollef MH Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000 ; 31 (supp l). S131 - S138.
9. Kollef MH, Sherman G., Ward S., Fraser VJ Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999 ; 115: 462-474.
10. Iregui M., Ward S., Sherman G., Fraser VJ, Kolleff MH Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002 ; 122: 262-268.
11. Mathevon T., Souweine B., Traoré O., Aublet B., Caillaud D. ICU-acquired nosocomial infection: impact of delay of adequate antibiotic treatment. Scand J Infect Dis. 2002 ; 34: 831-835.
12. Clec'h C., Timsit JF, Lassence A., et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med. 2004 ; 30: 1327-1333.
13. Patel PJ, Leeper KV, McGowan JE Epidemiology and microbiology of hospital-acquired pneumonia. Sem Respir Crit Care Med. 2002 ; 23: 415-425.
14. Luna CM, Aruj P., Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J. 2006 ; 27: 158-164.
15. Jimenez P., Torres A., Rodrequez-Roisin R., et al. Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med. 1989 ; 17: 882-885.
16. Fagon JY, Chastre J., Hance AJ, Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluation attributable mortality and hospital stay. Am J Med. 1993 ; 94: 281-288.
17. Collard HR, Saint S., Matthay MA Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003 ; 138: 494-501.
18. Kollef MH, Von Harz B., Prentice D., et al. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest. 1997 ; 112: 765-773.
19. American Thoracic Society and the Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir. Crit Care Med. 2005 ; 171: 388-416.
20. Tablan OC, Anderson LJ, Besser R., Bridges C., Hajjeh R. and the CDC Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing healthcare associated pneumonia 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004 ; 53 (RR- 3). 1-36.
21. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972 ; 77: 701-706.
22. Wunderink R. Clinical criteria in the diagnosis of ventilator-associated pneumonia. Chest. 2000 ; 117: 191S - 194S.
23. Fagon J., Chastre J., Hance AJ, Domart Y., Trouillett J., Gibert C. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest. 1993 ; 103: 547-553.
24. Timsit JF, Cheval C., Gachot B., et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med. 2001 ; 27: 640-647.
25. Helling TS, Van Way C. III, Krantz S., Bertram K., Steward A. The value of clinical judgment in the diagnosis of nosocomial pneumonia. Am J Surg. 1996 ; 171: 570-575.
26. Torres A., el-Ebiary M., Padro L., et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med. 1994 ; 149: 324-331.
27. Kirtland SH, Corley DE, Winterbauer RH, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest. 1997 ; 112: 445-457.
28. Fabregas N., Ewig S., Torres A., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax. 1999 ; 54: 867-873.
29. Montravers P., Fagon JY, Chastre J., et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis. 1993 ; 147: 38-44.
30. Souweine B., Veber B., Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med. 1998 ; 26: 236-244.
31. Papazian L., Thomas P., Garbe L., et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1995 ; 152: 1982-1991.
32. Kollef MH, Bock KR, Richards RD, Hearns ML The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med. 1995 ; 122: 743-748.
33. Marik PE, Brown WJ A comparison of bronchoscopic vs blind protected specimen brush sampling in patients with suspected ventilator-associated pneumonia. Chest. 1995 ; 108: 203-207.
34. Wood AY, Davit AJ, Ciraulo DL, et al. A prospective assessment of diagnostic efficacy of blind protective bronchial brushings compared to bronchoscope-assisted lavage, bronchoscope-directed brushings, and blind endotracheal aspirates in ventilator-associated pneumonia. J Trauma. 2003 ; 55: 825-834.
35. Shorr AF, Sherner JH, Jackson WL, Kollef MH Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2005 ; 33: 46-53.
36. The Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. NEJM. 2006 ; 355: 2619-2630.
37. Pugin J., Auckenthaler R., Mili N., Janssens JP, Lew PD, Suter PM Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic ''blind'' bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991 ; 143: 1121-1129.
38. Johanson WG, Seidenfeld JJ, Gomez P., De Los Santos R., Coalson JJ Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis. 1988 ; 137: 259-264.
39. Kahn FW, Jones JM Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis. 1987 ; 155: 862-869.
40. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis. 1987 ; 155: 855-861.
41. Flanagan PG, Findlay GP, Magee JT, Ionescu AA, Barnes RA, Smithies MN The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Med. 2000 ; 26: 20-30.
42. Rajasekhar T., Anuradha K., Suhasini T., Lakshmi V. The role of quantitative cultures of non-bronchoscopic samples in ventilator associated pneumonia. Indian J Med Microbiol. 2006 ; 24: 107-113.
43. Veinstein A., Brun-Buisson C., Derrode N., et al. Validation of an aligorithm based on direct examination of specimens in suspected ventilator-associated pneumonia. Intensive Care Med. 2006 ; 32: 676-683.
44. Croce MA, Swanson JM, Magnotti LJ, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma. 2006 ; 60: 523-528.
45. Garrard CS, A'Court CD The diagnosis of pneumonia in the critically ill. Chest. 1995 ;108(suppl): 17S - 25S.
46. Luna CM, Blanzaco D., Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003 ; 31: 676-682.
47. Schurink CAM, Van Nieuwenhoven CA, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med. 2004 ; 30: 217-224.
48. Swoboda SM, Dixon T., Lipsett PA Can the clinical pulmonary infection score impact ICU antiobiotic days ? Surg Infect. 2006 ; 7: 331-339.
49. Fartoukh M., Maitre B., Honoré S., Cerf C., Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation. The clinical pulmonary infection score revisited. Am J Respir Crit Care Med. 2003 ; 168: 173-179.
50. Singh N., Rogers P., Atwood CW, Wagener MM, Yu VL Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Resp Crit Care Med. 2000 ; 162: 505-511.
51. Luyt CE, Chastre J., Fagon JY and the VAP Trial Group. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004 ; 30: 844-852.
52. Dreyfuss D., Mier L., Le Bourdelles G., et al. Clinical significance of borderline quantitative protected brush specimen culture results. Am Rev Respir Dis. 1993 ; 147: 946-951.
53. Luna CM, Vujacich P., Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997 ; 111: 676-685.
54. Rello J., Gallego M., Mariscal D., Sonora R., Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997 ; 156: 196-200.
55. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998 ; 113: 412-420.
56. Sanchez-Nieto JM, Torres A., Garcia-Cordoba F., et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med. 1998 ; 157: 371-376.
57. Rello J., Vidaur L., Sandiumenge A., et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004 ; 32: 2183-2190.
58. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies [consensus statement]. Am J Respir Crit Care Med. 1995 ; 153: 1711-1725.
59. Dennesen PJ, van der Ven Ajam, Kessels AGH, Ramsay G., Bonten MJM. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001 ; 163: 1371-1375.
60. Chua TDJ, File TM Ventilator-associated pneumonia: gearing towards shorter-course therapy. Curr Opin Infect Dis. 2006 ; 19: 185-188.
61. Ibrahim EH, Ward S., Sherman G., Schaiff R., Fraser VJ, Kollef MH Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 2001 ; 29: 1109-1115.
62. Micek ST, Ward S., Fraser VJ, Kollef MH A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004 ; 125: 1791-1799.
63. Kollef MH, Kollef KE Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest. 2005 ; 128: 2706-2713.
64. Chastre J., Wolff M., Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA. 2003 ; 290: 2588-2598.
65. Andrews CP, Coalson JJ, Smith JD, Johanson WG Jr. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest. 1981 ; 80: 254-258.
66. Timsit JF, Cheval C., Gachot B., et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med. 2001 ; 27: 640-647.